Rose L. Szabady

1.4k total citations · 1 hit paper
17 papers, 1.0k citations indexed

About

Rose L. Szabady is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Rose L. Szabady has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Rose L. Szabady's work include Gut microbiota and health (7 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Cancer Research and Treatments (3 papers). Rose L. Szabady is often cited by papers focused on Gut microbiota and health (7 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Cancer Research and Treatments (3 papers). Rose L. Szabady collaborates with scholars based in United States, United Kingdom and Japan. Rose L. Szabady's co-authors include Fanny Franchini, Oliver J. Harrison, Olivier Boulard, Emily Thornton, Stefanie Kirchberger, Daniel Royston, Fiona Powrie, Harris D. Bernstein, Janine H. Peterson and Beth A. McCormick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Rose L. Szabady

17 papers receiving 993 citations

Hit Papers

Innate lymphoid cells sustain colon cancer through produc... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose L. Szabady United States 12 413 374 217 190 174 17 1.0k
Pierre Lapaquette France 18 370 0.9× 968 2.6× 367 1.7× 123 0.6× 96 0.6× 27 1.6k
Claire Pearson United Kingdom 15 671 1.6× 362 1.0× 138 0.6× 224 1.2× 82 0.5× 26 1.1k
Jennifer Raisch France 8 82 0.2× 655 1.8× 124 0.6× 112 0.6× 193 1.1× 12 908
Janine Zahlten Germany 20 471 1.1× 490 1.3× 67 0.3× 45 0.2× 38 0.2× 32 1.2k
Christopher D. Johnston United States 16 113 0.3× 689 1.8× 79 0.4× 98 0.5× 270 1.6× 36 1.2k
Isabella Pesce Italy 12 166 0.4× 227 0.6× 103 0.5× 44 0.2× 105 0.6× 16 642
Dario Lehoux United States 16 87 0.2× 366 1.0× 187 0.9× 75 0.4× 78 0.4× 36 784
Ezra Aksoy Belgium 20 814 2.0× 449 1.2× 85 0.4× 75 0.4× 187 1.1× 24 1.3k
Abby L. Geis United States 9 126 0.3× 988 2.6× 107 0.5× 166 0.9× 438 2.5× 13 1.4k
Pedro Escoll France 18 607 1.5× 702 1.9× 92 0.4× 33 0.2× 73 0.4× 34 1.5k

Countries citing papers authored by Rose L. Szabady

Since Specialization
Citations

This map shows the geographic impact of Rose L. Szabady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose L. Szabady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose L. Szabady more than expected).

Fields of papers citing papers by Rose L. Szabady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose L. Szabady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose L. Szabady. The network helps show where Rose L. Szabady may publish in the future.

Co-authorship network of co-authors of Rose L. Szabady

This figure shows the co-authorship network connecting the top 25 collaborators of Rose L. Szabady. A scholar is included among the top collaborators of Rose L. Szabady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose L. Szabady. Rose L. Szabady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nooij, Sam, Elisabeth M. Terveer, Emily Crossette, et al.. (2024). Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study. Journal of Crohn s and Colitis. 18(9). 1381–1393. 14 indexed citations
2.
Prince, Amanda, Rajita Menon, Jason M. Norman, et al.. (2024). 607 CONSORTIUM-IO: a phase 1 study evaluating a combination of an 11-strain bacterial consortium (VE800) and nivolumab in treatment of select refractory or metastatic cancers. Regular and Young Investigator Award Abstracts. A698–A699. 2 indexed citations
5.
Foley, Sage E., Michael J. Grey, Heidi De Luca, et al.. (2021). Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Microbiome. 9(1). 183–183. 83 indexed citations
6.
Davar, Diwakar, Judy S. Wang, Michael Cecchini, et al.. (2020). Abstract CT246: Consortium-IO: A safety and efficacy study of VE800 in combination with nivolumab in previously treated patients with select advanced metastatic cancers. Cancer Research. 80(16_Supplement). CT246–CT246. 4 indexed citations
7.
Frankel, Arthur E., Kenya Honda, Bruce Roberts, et al.. (2019). Precision probiotic therapy enhances immune checkpoint therapy efficacy in melanoma bearing mice.. Journal of Clinical Oncology. 37(15_suppl). e14195–e14195. 1 indexed citations
8.
Palace, Samantha G., Megan K. Proulx, Rose L. Szabady, & Jon D. Goguen. (2018). Gain-of-Function Analysis Reveals Important Virulence Roles for the Yersinia pestis Type III Secretion System Effectors YopJ, YopT, and YpkA. Infection and Immunity. 86(9). 12 indexed citations
9.
Stein, Richard R., Takeshi Tanoue, Rose L. Szabady, et al.. (2018). Computer-guided design of optimal microbial consortia for immune system modulation. eLife. 7. 62 indexed citations
10.
Szabady, Rose L., Anneke Lubben, Sage E. Foley, et al.. (2018). Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis. Journal of Clinical Investigation. 128(9). 4044–4056. 51 indexed citations
11.
Boll, Erik J., Rose L. Szabady, Karen A. Krogfelt, et al.. (2017). Enteroaggregative Escherichia coli Adherence Fimbriae Drive Inflammatory Cell Recruitment via Interactions with Epithelial MUC1. mBio. 8(3). 35 indexed citations
12.
Kirchberger, Stefanie, Daniel Royston, Olivier Boulard, et al.. (2013). Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. The Journal of Experimental Medicine. 210(5). 917–931. 412 indexed citations breakdown →
13.
Szabady, Rose L. & Beth A. McCormick. (2013). Control of Neutrophil Inflammation at Mucosal Surfaces by Secreted Epithelial Products. Frontiers in Immunology. 4. 220–220. 49 indexed citations
14.
Szabady, Rose L., et al.. (2010). TagA is a secreted protease of Vibrio cholerae that specifically cleaves mucin glycoproteins. Microbiology. 157(2). 516–525. 63 indexed citations
15.
Szabady, Rose L., Mary A. Lokuta, Kevin Walters, Anna Huttenlocher, & Rodney A. Welch. (2009). Modulation of Neutrophil Function by a Secreted Mucinase of Escherichia coli O157∶H7. PLoS Pathogens. 5(2). e1000320–e1000320. 38 indexed citations
16.
Peterson, Janine H., Rose L. Szabady, & Harris D. Bernstein. (2006). An Unusual Signal Peptide Extension Inhibits the Binding of Bacterial Presecretory Proteins to the Signal Recognition Particle, Trigger Factor, and the SecYEG Complex. Journal of Biological Chemistry. 281(14). 9038–9048. 55 indexed citations
17.
Szabady, Rose L., Janine H. Peterson, Kristen M. Skillman, & Harris D. Bernstein. (2004). An unusual signal peptide facilitates late steps in the biogenesis of a bacterial autotransporter. Proceedings of the National Academy of Sciences. 102(1). 221–226. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026